Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 12.83.
Forward PE Ratio (12.83) = Close Price ($26.34) / Consensus Forward EPS ($2.05)
FORWARD PE RATIO
12.83
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-35.58%
vs the sector median at left
Baxter International Inc.
Market Cap
$13.62B
Forward PE Ratio
12.83
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Baxter International Inc. (BAX) | $13.62B | 12.83 |
| Exelixis, Inc. (EXEL)vs › | $13.59B | 18.14 |
| Revvity, Inc. (RVTY)vs › | $13.92B | 23.29 |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.22B | 26.08 |
| Tempus AI, Inc. (TEM)vs › | $12.74B | N/A |
| The Cooper Companies, Inc. (COO)vs › | $14.87B | 16.46 |
| Solventum Corporation (SOLV)vs › | $15.51B | 12.51 |
| Align Technology, Inc. (ALGN)vs › | $11.64B | 14.40 |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 37.61 |
| DaVita Inc. (DVA)vs › | $11.16B | 11.71 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
12.8
consensus next-FY EPS
At today's $26.34 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $2.05 | $1.98 – $2.08 | 8 | 12.8x |
| 2027-12-31 | $2.04 | $1.70 – $2.15 | 9 | 12.9x |
| 2028-12-31 | $2.17 | $1.44 – $3.09 | 3 | 12.2x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
